First isolations of Segniliparus rugosus from patients with cystic fibrosis
- PMID: 17670929
- PMCID: PMC2045363
- DOI: 10.1128/JCM.00765-07
First isolations of Segniliparus rugosus from patients with cystic fibrosis
Abstract
We report three cases of the new genus Segniliparus isolated from patients with cystic fibrosis. All isolates were unambiguously identified by 16S rRNA gene sequencing as Segniliparus rugosus (GenBank accession no. AY 60892). Drug susceptibility results that may enhance treatment for cystic fibrosis patients with this opportunistic pathogen are presented.
Figures
Similar articles
-
Segniliparus rugosus from the sputum of a child with cystic fibrosis in Ecuador: challenges in bacterial identification.New Microbes New Infect. 2020 Mar 18;35:100668. doi: 10.1016/j.nmni.2020.100668. eCollection 2020 May. New Microbes New Infect. 2020. PMID: 32461807 Free PMC article.
-
Segniliparus rugosus infection, Australia.Emerg Infect Dis. 2009 Apr;15(4):611-3. doi: 10.3201/eid1504.081479. Emerg Infect Dis. 2009. PMID: 19331748 Free PMC article. No abstract available.
-
First case of Segniliparus rotundus pneumonia in a patient with bronchiectasis.J Clin Microbiol. 2011 Sep;49(9):3403-5. doi: 10.1128/JCM.01023-11. Epub 2011 Jul 13. J Clin Microbiol. 2011. PMID: 21752969 Free PMC article.
-
High prevalence of inducible clindamycin resistance among Staphylococcus aureus isolates from patients with cystic fibrosis.J Cyst Fibros. 2008 May;7(3):206-9. doi: 10.1016/j.jcf.2007.07.010. Epub 2007 Aug 24. J Cyst Fibros. 2008. PMID: 17719856
-
Regimens for eradicating early Pseudomonas aeruginosa infection in children do not promote antibiotic resistance in this organism.J Cyst Fibros. 2009 Jan;8(1):43-6. doi: 10.1016/j.jcf.2008.08.001. Epub 2008 Oct 1. J Cyst Fibros. 2009. PMID: 18829398
Cited by
-
Genomic and proteomic features of mycobacteriophage SWU1 isolated from China soil.Gene. 2015 Apr 25;561(1):45-53. doi: 10.1016/j.gene.2015.02.053. Epub 2015 Feb 19. Gene. 2015. PMID: 25701596 Free PMC article.
-
Segniliparus rugosus from the sputum of a child with cystic fibrosis in Ecuador: challenges in bacterial identification.New Microbes New Infect. 2020 Mar 18;35:100668. doi: 10.1016/j.nmni.2020.100668. eCollection 2020 May. New Microbes New Infect. 2020. PMID: 32461807 Free PMC article.
-
A Novel Depsipeptide Produced by Paenibacillus alvei 32 Isolated from a Cystic fibrosis Patient.Probiotics Antimicrob Proteins. 2013 Mar;5(1):18-25. doi: 10.1007/s12602-012-9121-z. Probiotics Antimicrob Proteins. 2013. PMID: 26782601
-
Complete genome sequence of Segniliparus rotundus type strain (CDC 1076).Stand Genomic Sci. 2010 Mar 30;2(2):203-11. doi: 10.4056/sigs.791633. Stand Genomic Sci. 2010. PMID: 21304703 Free PMC article.
-
Importance of the identification of Segniliparus species from pulmonary infection.New Microbes New Infect. 2018 May 25;25:1-2. doi: 10.1016/j.nmni.2018.05.002. eCollection 2018 Sep. New Microbes New Infect. 2018. PMID: 29988754 Free PMC article. No abstract available.
References
-
- Butler, W. R., M. M. Floyd, J. Brown, S. R. Toney, M. Daneshvar, R. C. Cooksey, J. Carr, A. Steigerwalt, and N. Charles. 2005. Novel mycolic acid-containing bacteria in the family Segniliparaceae fam. nov., including the genus Segniliparus gen. nov., with descriptions of Segniliparus rotundus sp. nov., and Segniliparus rugosus sp. nov. Int. J. Syst. Evol. Microbiol. 55:1615-1624. - PubMed
-
- CLSI. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. CLSI document M100-S16 (ISBN 1-56238-588-7). CLSI, Wayne, PA.
-
- Griffith, D. E., T. Aksamit, B. A. Brown-Elliott, A. Catanzaro, C. Daley, F. Gordin, S. M. Holland, R. Horsburgh, G. Huitt, M. F. Iademarco, M. Iseman, K. Olivier, S. Ruoss, C. Fordham von Reyn, R. J. Wallace, Jr., and K. Winthrop on behalf of the ATS Mycobacterial Diseases Subcommittee. 2007. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367-416. - PubMed
-
- NCCLS. 2003. Susceptibility testing of mycobacteria, nocardiae, and other aerobic actinomycetes; approved standard. NCCLS document M24-A (ISBN 1-56238-500-3). NCCLS, Wayne, PA. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases